Cronos (CRON) EBT Margin Growth (1y) (2019 - 2026)
Cronos (CRON) EBT Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 342.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -166.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,404.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,258.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 8,812.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,773.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 132.00 |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | -3,530.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,530.00 |
| Dec 31, 2025 | 149,153.00 |
| Sep 30, 2025 | 1,787.00 |
| Jun 30, 2025 | -33,301.00 |
| Mar 31, 2025 | 8,745.00 |
| Dec 31, 2024 | -132,904.00 |
| Sep 30, 2024 | 4,890.00 |
| Jun 30, 2024 | -562.00 |
| Mar 31, 2024 | 26,380.00 |
| Dec 31, 2023 | -29,508.00 |
| Sep 30, 2023 | 14,037.00 |
| Jun 30, 2023 | 4,317.00 |
| Mar 31, 2023 | -14,684.00 |
| Dec 31, 2022 | -197,377.00 |
| Sep 30, 2022 | -200,277.00 |
| Jun 30, 2022 | 107,866.00 |
| Mar 31, 2022 | 115,246.00 |
| Dec 31, 2021 | 298,117.00 |
| Sep 30, 2021 | 123,530.00 |
| Jun 30, 2021 | -5,471.00 |